Ichiza "Refnot": Oogqirha kwakhona unyango lomhlaza

Imihlaza, ngelishwa, zicwadi kunzima kakhulu ukunyanga. Kwaye abantu abaninzi baye baqonde imeko esibi sele kwizigaba zokuqala xa amathuba unyango okanye noxolelo iphantsi kakhulu. Noko ke, kukho ichiza into enegalelo ekwenzeni ukutshatyalaliswa iiseli zomhlaza. "Refnot" libhekisela ndlela. Ukuphonononga amagqirha kwi amayeza athethe ngokwabo.

elapha

"Refnot" impendulo kumagqirha malunga ezahlukeneyo libhekisela kwiqela arhente anticancer. oncologists abaninzi baye basebenzisa ngempumelelo ichiza yonyango iindidi zezifo neoplastic. Kuquka umhlaza esiswini, amathumbu kunye nemiphunga.

release Form

Ifumaneka iziyobisi "Refnot" njengendlela lokulungiselela ngenaliti lolawulo ongama ngakumbi. eyona nto osebenzayo kuthiwa - leofiziliat. Ayikho enye indlela yokukhululwa nje ayikho. Ngoko ke, ukuba ethile ukuze ahlangabezane kunikezo ukuthenga ichiza ngokohlobo iipilisi okanye isipreyi, amayeza kunye nezinye izinto, ngoko omnye elinamanci ekhulwini isiqinisekiso sinokuthi oku ubuqhophololo ngamanzi acocekileyo.

nomakhi

Ichiza ifumaneka eRashiya. Enyanisweni, wenza ke elilodwa lomenzi lilo, kakhulu, waba kummandla Russian Federation. Waphuhliswa iziyobisi "Refnot" nto leyo kwakhona kuya kuba ngaphantsi kancinane ngo-2002. Inkampani, nto leyo waqhuba umfuniselo, uphando kunye nemveliso, - "Farmaklon". Yaye kuphela emva kokuba elilodwa lomenzi wechiza ngo-2006, yanikwa inkampani "Refnot Farm." Yaye kuphela emva kokuba ichiza ifumene ehlabathini kwaye kuthengiswe ngokumiselwa. inikelwa kuphela njenge-arhente Esalingwayo ukuba izigulane ezinomhlaza phambi 2006. I ihlolwe ichiza kumanqanaba ahlukeneyo sifo, into leyo eyaye amandla kunye nobuthathaka yayo.

imiphumela emibi

Ethetha ukulungiselela ezifana "nokubuyekeza Refnot 'loogqirha leyo buyaphikisana kakhulu, akunakuthethwa malunga ubuthathaka bakhe. Ngokukodwa, iziphumo ebezingalindelekanga. Umzekelo, zibandakanya ukwanda okwexeshana lobushushu ngu degrees 1-3 eziqhelekileyo, ukwanda novakalelo, nto leyo ukuphuhlisa kwizigulane abafumana ichiza. Ukongeza, isicelo lokuqala iphawulwe ububomvu okanye ukukruquka kwindawo of inaliti. Njengomgaqo, ngenye imini zonke iziphumo ebezingalindelekanga shwaka bebodwa. Kwezinye iimeko, indlela "ibuprofen 'ukuba iqondo lobushushu emzimbeni bunjani.

Xa kufuneka ukuba uthathe

Kuyaphawuleka ukuba umphumo ilungileyo ubonisa ukulungiswa xa isetyenziswa ukuze ukunyanga yamathumba umhlaza webele kumanqanaba ahlukeneyo. Ngokuqhelekileyo, ukuqinisekisa bachache ngokupheleleyo kwinqanaba lokugqibela uphuhliso umhlaza kunye nokwanda metastases wonke umzimba, akukho namnye unako, kodwa ukuphucula imeko yomguli ichiza sikarhulumente. Ngokukodwa, kuba unyango kwangumqondiso xa uthomalaliso ngqo ukuba ukulwa ithumba, kwaye ukunciphisa intlungu sifo. Ukongeza, oncologists ngakumbi nangakumbi Kucetyiswa ukuba basebenzise iindlela "Refnot" ngexesha ichemotherapy. Yinyaniso okanye bubuxoki malunga nefuthe ngokungummangaliso ichiza, kunzima ukuyiqonda.

Ukuba Ndiyathemba ukuba umqondiso?

Ugqirha Onge kuziqinisekisa umguli okanye intsapho yakhe zemo sinethemba. Ngokunjalo angabathembi. Amaninzi, oncologists zama ukuba bammise phambi izibakala ngeku. Kungenxa yoko le nto ukuqonda ukuba "Refnot" Eneneni (yinyaniso okanye bubuxoki ilikhubalo ekwimo ichiza) inceda abantu, kuba nzima kakhulu. Ukuthetha umhlaza, awukwazi ukuqiniseka 100 ekhulwini ukuba into okanye ezinye iindlela okanye indlela zonyango bekuya kuba olusebenzayo. Isikakhulu sifo phambili isuka yenze kuxhokonxa ukusasazeka kwalo nto. Noko ke, ithemba umqondiso kufuneka kusoloko, kungenjalo ayisoze yenzeke.

ukusebenza beziyobisi

Abavelisi bathi indlela unalo isiphumo antitumor ngqo ngokusekelwe kwi nokunqandwa in vitro, elonakalisileyo iiseli umhlaza amabi, kumanqanaba ahlukeneyo. Ukuqulunqwa iziphumo zingasetyenziswa nangaliphi na ixesha lesi sifo. Noko ke, njengoko kuvela, akukho kakuhle kakhulu "Refnot" 4st kwi unyango lomhlaza esiswini. Izimvo isicelo ayikho ezihle kakhulu, kodwa ke makuqatshelwe ukuba intlungu liyehla kakhulu. Ngoko ke, ukusetyenziswa ichiza kunokwenzeka, ukuba zonke iingcebiso kunokwenzeka nezonyango. Xa oku ubuthi kwi "Refnot" izihlandlo ezilikhulu ngaphantsi koko of TNF.

ukusebenza

Xa ukuhlola ichiza, kwaye kwaqatshelwa ukuba kwandisa impumelelo nechemotherapy. Ngokukodwa, iziyobisi ezifana:

• "Cytosar";
• "Actinomycin D";
• "5-ababhalise okokuqala bebe yi".

Onke la machiza kunzima ngokwaneleyo ukuba angene kungena emzimbeni, entle kwaye luchaphazela ngayo. "Reviews Refnot 'loogqirha leyo efana kule nkalo, ukuvumela ukuphelisa ukuxhathisa. Oko kukuthi, ukuba kunokwenzeka kwaye enqwenelekayo ukusebenzisa ichemotherapy ukuze andise impumelelo yawo, kwaye okona kubalulekileyo - ukunciphisa inani lezicelo yayo. Umzimba ufumana iqhezu izinto eziyityhefu zinqanda ukukhula kunye nophuhliso ziiseli zomhlaza.

test

Kudala phambi kokuba bangene isicelo iziyobisi kuqhutywa ulingo lonyango kunye imifuniselo eyahlukeneyo eMoscow St Petersburg. Uvavanyo lwenziwe kumabakala ahlukeneyo iiseli zomhlaza. E Moscow, Russian Cancer Research Centre ogama emva NN Blokhin zaye zenziwa ulingo lwezonyango ngayo kwisigaba sokuqala, apho yatyhilwa ukuba ichiza zinetyhefu esezantsi kakhulu. Ngenxa yoko, ukubuyekeza kokuqala "Refnote" wafumana ezihle phakathi koogqirha. Ulingo lwezonyango zaqhutywa carcinomas cell carcinoma ye intloko entanyeni, nto leyo ebalulekileyo. Kamva, eSt Petersburg kwi NN Petrov Research Institute of Oncology ogama zaqhutywa kuhlolisiswe kwi zigaba yesibini neyesithathu zomhlaza. Ngokukodwa, phambili ekuhlaleni kunye nomhlaza webele kuwenza xa zidityaniswe ne ichemotherapy. Kwaye ichiza lubonise iziphumo ezigqwesileyo apha. Emva koko, "Refnota" reviews ngenyathelo zaba ngcono.

Amaqela Treatment esifundweni

Ukuze ufumanise ukuba olusebenzayo ichiza, bakhethwa ngabantu (kwi yokuqala kunye kwetyala yesibini), zidibene izinto ezikhethekileyo. Ngokukodwa, nto;

1. okulindeleke. kwadingeka ukuba ubuncinane iinyanga ezintathu.
2. Age. Akamele ukuba kwiminyaka engaphezu kwama-75.
3. Kwemvume isigulane. Ayizizo zonke ukwimeko enjalo ukulungele ukuthatha imingcipheko.
4. Isimo ngokubanzi. Obekumele ukuba sibe uluhlu 0-2 WHO.
5. yesiqinisekiso elipheleleyo kokuxilongwa ngaphambili.

Ngaba ngokuzitofela ichiza idosi yemihla ngemihla ye-100 000 IU. Kulo mzekelo, isigulane ngasinye indlela ngamnye we nokudlulisela ichiza. Ngokomzekelo, phambi kokuba kuyiwe ekhosini ichemotherapy ngokuyimfuneko kuqhutywa ngenaliti (100 000 IU). Ngokubanzi, ichiza kakuhle kubonakele zikumanqanaba ahlukeneyo esi sifo, ngoko ke isifundo baza baqhubeka. Kubalulekile ukuphawula ukuba izigulane inxaxheba kule experiment nako ixesha elide, kwaye okona kubalulekileyo - isantya nokukhula iiseli zomhlaza.

ziziphumo zophando

Emva ulingo lwezonyango zaye zagqitywa, bonke oogqirha ngamxhelo mnye beza kwisigqibo sokuba siyobisi ngempumelelo Wabonakala unyango somhlaza webele ile ichemotherapy. Kungenxa yoko le nto kucetyiswa kwiimeko ezinjalo, phantse ukukhathaza abanye abantu namhlanje. Yiloo nto nokungaphumeleli kangaka "Refnot" 4st kwi unyango lomhlaza esiswini. Ukubuyekeza oku nje kwizalamane yezigulane, kodwa oogqirha ngokwabo. Baba ngabokuqala wabona kwawo phantse epheleleyo beziyobisi kwesi sifo. Kakade ke abantu ngokwabo, kwacaca ukuba "Refnot" asinto ilikhubalo, kodwa mnye kuphela amachiza kunokwenzeka, oko akuthethi kunceda.

Ndifanele isicelo?

Ukuba somdlavuza licebisa ngamandla ukusetyenziswa "Refnot 'ukuba ukwehlisa ukusasazeka kwesi sifo, oko kusafuneka ukuphulaphula icebiso lakhe. Kwiimeko ezininzi, iingcali ndiyayiqonda into enokusinceda neqonga elithile umhlaza ngakumbi. Ukongeza, i-ncomo ngokwabo oogqirha malunga ichiza, nangona eziphikisanayo, kodwa enye into efanayo - Chemotherapy enye zoncedo nje alifumani. "Refnot" phantse non-ezingenabungozi, lineziphumo ebezingalindelekanga ezimbalwa, eziveliswe yabalinga ziingcali Russian, ukhetheke ihlabathi, ngenxa yoko, musa ukuthembela kungekho sizathu ngaye. Ukuba kukho isindululo gqirha ukuya, imfuneko ukusebenzisa iyeza. Ingakumbi xa kuziwa umhlaza webele, apho liphathwa ichemotherapy.